Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Structured recovery pathway tested for faster healing after placenta previa cesarean

NCT ID NCT07830914

NEW Symptom relief Sponsor: Assiut University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 21, 2026 · Last updated Sep 21, 2026

Summary

Researchers are testing whether a standardized Enhanced Recovery After Surgery (ERAS) pathway improves recovery for women who have a cesarean delivery because of placenta previa. The study includes 100 women with a singleton pregnancy and a confirmed placenta previa who are scheduled for elective cesarean delivery. Half receive the ERAS protocol, which includes specific fasting rules, pain control with fewer opioids, early eating and walking, and early catheter removal, while the other half receive usual care. The main measure is how long women stay in the hospital, with additional checks on pain, satisfaction, and other recovery outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Enhanced Recovery After Surgery (ERAS) protocol, a structured care pathway for cesarean delivery
What this could lead to
If the ERAS pathway helps, it could become a standard approach for cesarean delivery in women with placenta previa, potentially shortening hospital stays and improving comfort during recovery.
What could go wrong
This is a single-center study of 100 women, so results may not apply broadly. ERAS protocols are already used in many surgeries, and benefits seen here might reflect better overall care rather than the protocol itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Mar 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Singleton pregnancy * Sonographic diagnosis of placenta previa * Scheduled for elective cesarean delivery * Ability to provide informed consent Exclusion Criteria: * Severe medical diseases affecting postoperative recovery including hypertension and diabetes mellitus * Hemodynamic instability before surgery * ICU admission immediately after surgery * Refusal to participate

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Placenta previa are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Patient Satisfaction placenta praevia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Placenta previa

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.